Lewis H. Bender - Intens Therapeut, Westport, CT USA

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 30 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Phase II Randomized Window of Opportunity Trial Evaluating Cytotoxic and Immunomodulatory Effects of Intratumoral INT230-6 in Early Stage Breast Cancer: the INVINCIBLE Trial

Angel Arnaout,Lewis Bender,Megan Hopkins,Vanessa Lopez Ozuna,Linda Liao,Susan Robertson,Vida Talebian,Kianoosh Keyhanian,Arif Awan,Franco Abbate,Ian Walters,Gregory Pond,John Bartlett, Lazlo Radvanyi,Melanie Spears

CANCER RESEARCHno. 9 (2024)

引用0浏览0引用

Abstract PS16-03: Intratumoral dosing of INT230-6 in Early-Stage Breast Cancer Patients Induces Tumor Cell Necrosis and Immunomodulatory Effects: A Phase II Randomized Window-Of-Opportunity Study – the INVINCIBLE Trial

Cancer Researchno. 9_Supplement (2024): PS16-03

引用0浏览0引用

Intratumoral INT230-6 (cisplatin, Vinblastine, Shao) Alone or with Ipilimumab Prolonged Survival with Favorable Safety in Adults with Refractory Sarcomas

Christian Frederick Meyer,Matthew Ingham,James S. Hu,Giles Francis Whalen,Jacob Stephen Thomas,Anthony B. El-Khoueiry,Diana L. Hanna,Luis H. Camacho,Anthony J. Olszanski,Nilofer Saba Azad,Ian B. Walters,Lewis H. Bender,Lillian L. Siu,Albiruni Ryan Abdul Razak

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用0浏览0引用

Abstract PD11-02: PD11-02 A Phase II Randomized Window of Opportunity Trial Evaluating Cytotoxic and Immunomodulatory Effects of Intratumoral INT230-6 in Early Stage Breast Cancer: the INVINCIBLE Trial

Angel Arnaout,Susan Robertson,Kianoosh Keyhanian,Megan Hopkins,Linda Liao,Vida Talebian,Arif Awan,John MS Bartlett,Gregory R. Pond, Lazlo Radvanyi,Lewis H. Bender,Ian B. Walters,Vanessa Lopez Ozuna,Melanie Spears

Cancer researchno. 5_Supplement (2023): PD11-02

引用0浏览0引用

Safety and efficacy of INT230-6, a potential first-in-class intratumoral therapy, in monotherapy and in combination with pembrolizumab: Results from the IT-01 study [KEYNOTE-A10] in subjects with locally advanced, unresectable and metastatic breast cancer

Philippe Bedard,Lillian L. Siu,Jacob Thomas,Diana Hanna,Anthony J. Olszanski,Nilofer Azad,Giles Whalen,Matthew Ingham,Syed Mahmood,Lewis H. Bender,Ian B. Walters,Anthony El-Khoueiry

CANCER RESEARCH（2022）

引用1浏览0引用

Abstract P5-16-13: Safety and Efficacy of INT230-6, a Potential First-in-class Intratumoral Therapy, in Monotherapy and in Combination with Pembrolizumab: Results from the IT-01 Study [KEYNOTE-A10] in Subjects with Locally Advanced, Unresectable and Metastatic Breast Cancer

Philippe Bedard,Lillian L Siu,Jacob Thomas,Diana Hanna,Anthony J Olszanski,Nilofer Azad,Giles Whalen,Matthew Ingham,Syed Mahmood,Lewis H Bender,Ian B Walters,Anthony El-Khoueiry

Cancer Research（2022）

引用0浏览0引用

Intratumoral (IT) INT230-6 Can Cause Tumor Necrosis in Vivo: Preliminary Results of a Phase II Randomized Presurgical Window-of-opportunity Study in Early Breast Cancers (the INVINCIBLE Study)

Angel Arnaout,Melanie Spears,Arif Ali Awan,Susan Robertson,Kianoosh Keyhanian,Gregory Russell Pond,John Bartlett,Vanessa Lopez-Ozuna,Syed Mahmood,Lewis H. Bender,Ian B. Walters

Journal of clinical oncology（2022）

引用0浏览0引用

Effect of Intratumoral INT230-6 on Tumor Necrosis and Promotion of a Systemic Immune Response: Results from a Multicenter Phase 1/2 Study of Solid Tumors with and Without Pembrolizumab (PEM) [intensity IT-01; Merck KEYNOTE-A10]

Jacob Stephen Thomas,Anthony B. El-Khoueiry,Anthony J. Olszanski,Nilofer Saba Azad,Giles Francis Whalen,Diana L. Hanna,Matthew Ingham,Luis H. Camacho,Syed Mahmood,Lewis H. Bender,Ian B. Walters,Lillian L. Siu

Journal of clinical oncology（2022）

引用0浏览0引用

INT230-6 Monotherapy and in Combination with Ipilimumab (IPI) Across a Broad Spectrum of Refractory Soft Tissue Sarcomas (STS) [intensity IT-01; BMS#CA184-592]

Matthew Ingham,James S. Hu,Giles Francis Whalen,Jacob Stephen Thomas,Anthony B. El-Khoueiry,Diana L. Hanna,Anthony J. Olszanski,Christian Frederick Meyer,Nilofer Saba Azad,Luis H. Camacho,Syed Mahmood,Lewis H. Bender,Ian B. Walters,Lillian L. Siu,Albiruni Ryan,Abdul Razak

Journal of clinical oncologyno. 16_suppl (2022): 11515-11515

引用0浏览0引用

710 Safety and Survival Results from a Phase 1/2 Trial of Intratumoral Agent INT230–6 (cisplatin Vinblastine) Induces Immunological Cancer Cell Death Alone or with Pembrolizumab in Patients with Refractory, Metastatic Cancers

Jacob Thomas,Anthony El-Khoueiry,Diana Hanna,Anthony Olszanski,Nilofer Azad,Giles Whalen,Matthew Ingham,Luis Camacho,Franco Abbate,Lewis Bender,Ian Walters,Lillian Siu

Regular and Young Investigator Award Abstracts (2022)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn